Compile Data Set for Download or QSAR
Report error Found 38 Enz. Inhib. hit(s) with all data for entry = 10499
TargetFibroblast growth factor receptor 1(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541748BDBM541748(US11267815, Example 1)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 1(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541749BDBM541749(US11267815, Example 2)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541748BDBM541748(US11267815, Example 1)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 1(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541750BDBM541750(US11267815, Example 3)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541749BDBM541749(US11267815, Example 2)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 1(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541751BDBM541751(US11267815, Example 4)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541750BDBM541750(US11267815, Example 3)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 1(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541752BDBM541752(US11267815, Example 5)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541751BDBM541751(US11267815, Example 4)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 1(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541753BDBM541753(US11267815, Example 6)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541752BDBM541752(US11267815, Example 5)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 1(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541754BDBM541754(US11267815, Example 7)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541753BDBM541753(US11267815, Example 6)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 1(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541763BDBM541763(US11267815, Example 16)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 1(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541764BDBM541764(US11267815, Example 17)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 1(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541765BDBM541765(US11267815, Example 18)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 1(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541766BDBM541766(US11267815, Example 19)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 1(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541755BDBM541755(US11267815, Example 8)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541754BDBM541754(US11267815, Example 7)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 1(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541756BDBM541756(US11267815, Example 9)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541755BDBM541755(US11267815, Example 8)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 1(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541757BDBM541757(US11267815, Example 10)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541756BDBM541756(US11267815, Example 9)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 1(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541758BDBM541758(US11267815, Example 11)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541757BDBM541757(US11267815, Example 10)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 1(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541759BDBM541759(US11267815, Example 12)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541758BDBM541758(US11267815, Example 11)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 1(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541760BDBM541760(US11267815, Example 13)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541759BDBM541759(US11267815, Example 12)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 1(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541761BDBM541761(US11267815, Example 14)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541760BDBM541760(US11267815, Example 13)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 1(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541762BDBM541762(US11267815, Example 15)
Affinity DataIC50: 20nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541762BDBM541762(US11267815, Example 15)
Affinity DataIC50: 110nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541761BDBM541761(US11267815, Example 14)
Affinity DataIC50: 110nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541763BDBM541763(US11267815, Example 16)
Affinity DataIC50: 200nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541764BDBM541764(US11267815, Example 17)
Affinity DataIC50: 200nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541765BDBM541765(US11267815, Example 18)
Affinity DataIC50: 200nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetFibroblast growth factor receptor 4(Human)
Shanghai Ringene Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 541766BDBM541766(US11267815, Example 19)
Affinity DataIC50: 200nMAssay Description:(1) Preparation of 1×Kinase buffer; (2) Preparation of the gradient concentrations of the compounds: the concentration of the compounds to be tested ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent